Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: a discussion of chemical and biological data

ImageNet: A large-scale hierarchical image database

Deng, J., Dong, W., Socher, R., Li, L.-J., Li, K., & Fei-Fei, L. (2009) · 2009 IEEE Conference on Computer Vision and Pattern Recognition · doi:10.1109/cvpr.2009.5206848 · Cited by 65,333 · see citing works

Untitled work

(2014) · Cited by 33,419 · see citing works

Mastering the game of Go with deep neural networks and tree search

Silver, D., Huang, A., Maddison, C. J., Guez, A., Sifre, L., van den Driessche, G., Schrittwieser, J., Antonoglou, I., Panneershelvam, V., Lanctot, M., et al. (2016) · Nature · doi:10.1038/nature16961 · Cited by 15,612 · see citing works

DrugBank 5.0: a major update to the DrugBank database for 2018

Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404 · see citing works

Scenic: single-cell regulatory network inference and clustering.

Aibar, S., González-Blas, C. B., Moerman, T., Huynh-Thu, V. A., Imrichova, H., Hulselmans, G., Rambow, F., Marine, J.-C., Geurts, P., Aerts, J., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4463 · Cited by 6,520 · see citing works

Connectionist temporal classification: labelling unsegmented sequence data with recurrent neural networks

Graves, A., Fernández, S., Gomez, F., & Schmidhuber, J. (2006) · Proceedings of the 23rd international conference on Machine learning - ICML '06 · doi:10.1145/1143844.1143891 · Cited by 5,370 · see citing works

2008 IEEE Conference on Computer Vision and Pattern Recognition

(2008) · doi:10.1109/cvpr12618.2008 · Cited by 4,263 · see citing works

Handbook of Molecular Descriptors

Todeschini, R., & Consonni, V. (2000) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527613106 · Cited by 4,107 · see citing works

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · see citing works

ZINC 15 – Ligand Discovery for Everyone

Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224 · see citing works

Analyzing Learned Molecular Representations for Property Prediction

Yang, K., Swanson, K., Jin, W., Coley, C., Eiden, P., Gao, H., Guzman-Perez, A., Hopper, T., Kelley, B., Mathea, M., et al. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00237 · Cited by 1,923 · see citing works

Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology

Bera, K., Schalper, K. A., Rimm, D. L., Velcheti, V., & Madabhushi, A. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0252-y · Cited by 1,698 · see citing works

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609 · see citing works

The SIDER database of drugs and side effects

Kuhn, M., Letunic, I., Jensen, L. J., & Bork, P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1075 · Cited by 1,451 · see citing works

Gradient Flow in Recurrent Nets: The Difficulty of Learning LongTerm Dependencies

(2009) · Institute of Electrical and Electronics Engineers eBooks · doi:10.1109/9780470544037.ch14 · Cited by 1,312 · see citing works

Deep, Big, Simple Neural Nets for Handwritten Digit Recognition

Ciresan, D. C., Meier, U., Gambardella, L. M., & Schmidhuber, J. (2010) · Neural Computation · doi:10.1162/neco_a_00052 · Cited by 1,094 · see citing works

Molecular Transformer: A Model for Uncertainty-Calibrated Chemical Reaction Prediction

Schwaller, P., Laino, T., Gaudin, T., Bolgar, P., Hunter, C. A., Bekas, C., & Lee, A. A. (2019) · ACS Central Science · doi:10.1021/acscentsci.9b00576 · Cited by 1,078 · see citing works

Genetic and transcriptional evolution alters cancer cell line drug response

Ben-David, U., Siranosian, B., Ha, G., Tang, H., Oren, Y., Hinohara, K., Strathdee, C. A., Dempster, J., Lyons, N. J., Burns, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0409-3 · Cited by 931 · see citing works

ImageNet classification with deep convolutional neural networks

Krizhevsky (2012) · Medical Entomology and Zoology · Cited by 799 · see citing works

Biased signalling: from simple switches to allosteric microprocessors

Smith, J. S., Lefkowitz, R. J., & Rajagopal, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.229 · Cited by 746 · see citing works

Molecular similarity: a key technique in molecular informatics

Bender, A., & Glen, R. C. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b409813g · Cited by 616 · see citing works

‘It will change everything’: DeepMind’s AI makes gigantic leap in solving protein structures

Callaway, E. (2020) · Nature · doi:10.1038/d41586-020-03348-4 · Cited by 499 · see citing works

PotentialNet for Molecular Property Prediction

Feinberg, E. N., Sur, D., Wu, Z., Husic, B. E., Mai, H., Li, Y., Sun, S., Yang, J., Ramsundar, B., & Pande, V. S. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00507 · Cited by 485 · see citing works

Open TG-GATEs: a large-scale toxicogenomics database

Igarashi, Y., Nakatsu, N., Yamashita, T., Ono, A., Ohno, Y., Urushidani, T., & Yamada, H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku955 · Cited by 465 · see citing works

Open Targets Platform: new developments and updates two years on

Carvalho‐Silva, D., Pierleoni, A., Pignatelli, M., Ong, C. K., Fumis, L., Karamanis, N., Carmona, M., Faulconbridge, A., Hercules, A., McAuley, E., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1133 · Cited by 449 · see citing works

Separating host and microbiome contributions to drug pharmacokinetics and toxicity

Zimmermann, M., Zimmermann‐Kogadeeva, M., Wegmann, R., & Goodman, A. L. (2019) · Science · doi:10.1126/science.aat9931 · Cited by 427 · see citing works

The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group

Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M. F., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.003 · Cited by 414 · see citing works

Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet

Bender, A., & Cortés-Ciriano, I. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.009 · Cited by 405 · see citing works

When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis

Scannell, J. W., & Bosley, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147215 · Cited by 279 · see citing works

The role of ontologies in biological and biomedical research: a functional perspective

Hoehndorf, R., Schofield, P. N., & Gkoutos, G. V. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv011 · Cited by 265 · see citing works

Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization

Huang, R., Xia, M., Sakamuru, S., Zhao, J., Shahane, S. A., Attene‐Ramos, M. S., Zhao, T., Austin, C. P., & Simeonov, A. M. (2016) · Nature Communications · doi:10.1038/ncomms10425 · Cited by 259 · see citing works

In vitro to in vivo extrapolation for high throughput prioritization and decision making

Bell, S. M., Chang, X., Wambaugh, J. F., Allen, D., Bartels, M., Brouwer, K. L. R., Casey, W., Choksi, N. Y., Ferguson, S., Fraczkiewicz, G., et al. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.11.016 · Cited by 252 · see citing works

Sequences and consequences

Brenner, S. (2010) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2009.0221 · Cited by 244 · see citing works

Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades

Göller, A. H., Kuhnke, L., Montanari, F., Bonin, A., Schneckener, S., ter Laak, A., Wichard, J., Lobell, M., & Hillisch, A. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.001 · Cited by 215 · see citing works

What is a disease?: Disease, disability and their definitions

Scully, J. L. (2004) · The EMBO Reports · doi:10.1038/sj.embor.7400195 · Cited by 195 · see citing works

Chiron: translating nanopore raw signal directly into nucleotide sequence using deep learning

Teng, H., Cao, M. D., Hall, M. B., Duarte, T., Wang, S., & Coin, L. (2018) · GigaScience · doi:10.1093/gigascience/giy037 · Cited by 189 · see citing works

Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism

Williams, N. R., Heifets, B. D., Bentzley, B. S., Blasey, C., Sudheimer, K. D., Hawkins, J., Lyons, D. M., & Schatzberg, A. F. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0503-4 · Cited by 174 · see citing works

Molecular property prediction: recent trends in the era of artificial intelligence

Shen, J., & Nicolaou, C. A. (2019) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2020.05.001 · Cited by 157 · see citing works

Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder

Yoon, G., Petrakis, I. L., & Krystal, J. H. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3990 · Cited by 155 · see citing works

Annual Report 2018

Miranville, A., & Université de Poitiers, L. D. M. E. A. (2019) · AIMS Mathematics · doi:10.3934/math.2019.1.166 · Cited by 155 · see citing works

Toxicogenomics in Drug Discovery and Development: Mechanistic Analysis of Compound/Class-Dependent Effects Using the Drugmatrix®Database

Ganter, B., Snyder, R. D., Halbert, D. N., & Lee, M. D. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.7.1025 · Cited by 148 · see citing works

The clinical role of genetic polymorphisms in drug-metabolizing enzymes

Tomalik‐Scharte, D., Lazar, A., Fuhr, U., et al. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500462 · Cited by 136 · see citing works

Healthy skepticism: assessing realistic model performance

Brown, S. P., Muchmore, S. W., & Hajduk, P. J. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.01.012 · Cited by 126 · see citing works

Comprehensive Comparison of Ligand-Based Virtual Screening Tools Against the DUD Data set Reveals Limitations of Current 3D Methods

Venkatraman, V., Pérez‐Nueno, V. I., Mavridis, L., & Ritchie, D. W. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100263p · Cited by 125 · see citing works

Toxic Colors: The Use of Deep Learning for Predicting Toxicity of Compounds Merely from Their Graphic Images

Fernández, M., Ban, F., Woo, G., Hsing, M., Yamazaki, T., Leblanc, E., Rennie, P. S., Welch, W. J., & Cherkasov, A. R. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00338 · Cited by 117 · see citing works

A review of methods for solubility determination in biopharmaceutical drug characterization

Veseli, A., Žakelj, S., & Kristl, A. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1665062 · Cited by 117 · see citing works

A look at ligand binding thermodynamics in drug discovery

Claveria‐Gimeno, R., Vega, S., Abián, O., & Velázquez‐Campoy, A. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1297418 · Cited by 93 · see citing works

Snakes on a Plane: A perfect snap for bioimage analysis

Delgado-Gonzalo, R., Uhlmann, V., Schmitter, D., & Unser, M. A. (2014) · IEEE Signal Processing Magazine · doi:10.1109/msp.2014.2344552 · Cited by 72 · see citing works

KekuleScope: prediction of cancer cell line sensitivity and compound potency using convolutional neural networks trained on compound images

Cortés‐Ciriano, I., & Bender, A. (2019) · Journal of Cheminformatics · doi:10.1186/s13321-019-0364-5 · Cited by 63 · see citing works

Bias in Spontaneous Reporting of Adverse Drug Reactions in Japan

Matsuda, S., Kotonari, A. O. K. I., Kawamata, T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126413 · Cited by 58 · see citing works

Toward a new paradigm for the efficient in vitro–in vivo extrapolation of metabolic clearance in humans from hepatocyte data

Poulin, P., & Haddad, S. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23502 · Cited by 54 · see citing works

The germline genetic component of drug sensitivity in cancer cell lines

Menden, M. P., Casale, F. P., Stephan, J., Bignell, G. R., Iorio, F., McDermott, U., Garnett, M. J., Sáez-Rodríguez, J., & Stegle, O. (2018) · Nature Communications · doi:10.1038/s41467-018-05811-3 · Cited by 54 · see citing works

Impact of Genetic Polymorphism on Drug-Drug Interactions Mediated by Cytochromes: A General Approach

Tod, M., Nkoud-Mongo, C., & Gueyffier, F. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9530-2 · Cited by 45 · see citing works

Inulin as filler-binder for tablets prepared by direct compaction

Eissens, A. C., Bolhuis, G. K., Hinrichs, W. L. J., et al. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00201-9 · Cited by 40 · see citing works

KekuleScope: prediction of cancer cell line sensitivity and compound potency using convolutional neural networks trained on compound images

Cortés‐Ciriano, I., & Bender, A. (2019) · Apollo (University of Cambridge) · doi:10.17863/cam.43757 · Cited by 39 · see citing works

Systematic Analysis of Protein Targets Associated with Adverse Events of Drugs from Clinical Trials and Postmarketing Reports

Smit, I. A., Afzal, A. M., Allen, C. H. G., Svensson, F., Hanser, T., & Bender, A. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00294 · Cited by 24 · see citing works

Data Standardization, Pharmaceutical Drug Development, and the 3Rs

Kaufman, L. S., Gore, K., & Zandee, J. (2016) · ILAR Journal · doi:10.1093/ilar/ilw030 · Cited by 14 · see citing works

Curation and analysis of clinical pathology parameters and histopathologic findings from eTOXsys, a large database project (eTOX) for toxicologic studies

Pinches, M., Thomas, R., Porter, R., Camidge, L. J., & Briggs, K. A. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.05.021 · Cited by 14 · see citing works

ChemNet: A Transferable and Generalizable Deep Neural Network for Small-Molecule Property PredictionPreprint

Goh, G. B., Siegel, C., Vishnu, A., & Hodas, N. O. (2017) · arXiv (Cornell University) · Cited by 12 · see citing works

Systematic analysis of protein targets associated with adverse events of drugs from clinical trials and post-marketing reportsPreprint

Smit, I. A., Afzal, A. M., Allen, C. H. G., Svensson, F., Hanser, T., & Bender, A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.12.135939 · Cited by 3 · see citing works

The art and practice of structure-based drug design: A molecular modeling perspective

(1996) · doi:10.1002/(sici)1098-1128(199601)16:1

Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet

Bender, A., & Cortés-Ciriano, I. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.009 · Cited by 405 · see citing works

Artificial Intelligence for Drug Discovery: Are We There Yet?

Hasselgren, C., & Oprea, T. I. (2024) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-040323-040828 · Cited by 236 · see citing works

Artificial Intelligence in Small-Molecule Drug Discovery: A Critical Review of Methods, Applications, and Real-World Outcomes

Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18091271 · Cited by 61 · see citing works

Success stories of AI in drug discovery - where do things stand?

Mak, K.-K., Balijepalli, M. K., & Pichika, M. R. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.1985108 · Cited by 51 · see citing works

Pharma’s Bio-AI revolution

Bentwich, I. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103515 · Cited by 22 · see citing works

Widening bottlenecks in drug discovery Glimpses from Drug Discovery Technology Europe 2005

Högberg, T. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03490-2 · Cited by 3 · see citing works

In Silico and Ultrahigh‐Throughput Screenings (uHTS) in Drug Discovery: An Overview

Barh, D., Ahmad, S., & Bhattacharjee, A. (2012) · Pharmaceutical biotechnology · doi:10.1002/9783527632909.ch18 · Cited by 1 · see citing works

Drug discovery: selecting the optimal approach

Sams‐Dodd, F. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.03.015 · Cited by 81 · see citing works

Biological Knowledge Discovery Handbook: Preprocessing, Mining and Postprocessing of Biological Data

Elloumi, M., & Zomaya, A. Y. (2013) · Cited by 21 · see citing works

Complex Biological Data Mining and Knowledge Discovery

Kabli, F. (2019) · Biotechnology · doi:10.4018/978-1-5225-8903-7.ch011